A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy
Clinical trial NCT05139602 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05139602
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2027-12-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.